NUVB
insider transactionsNuvation Bio Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-261.8K
25.0K buy · 286.8K sell
Net value · 90d
-$1.2M
$118.2K in · $1.3M out
Sentiment · 90d
Net selling
8% buying · 92% selling
Open-market trades · 90d
4
25.0K buy · 286.8K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 90d
-
Buy·P
Director
$118.2K
25.0K sh · $4.73
Own +12%
-
Grant·A
Director
$0
123.4K sh
Own New
-
Grant·A
Director
$0
123.4K sh
Own New
-
Grant·A
Director
$0
123.4K sh
Own New
-
Grant·A
Director
$0
123.4K sh
Own New
-
Grant·A
Director
$0
123.4K sh
Own New
-
Grant·A
Director
$0
123.4K sh
Own New
-
Exercise·M
CHIEF REGULATORY OFFICER · 10b5-1
$0
36.8K sh
Own +21%
-
Sell·S
CHIEF REGULATORY OFFICER · 10b5-1
$184.3K
36.8K sh · $5.01
Own -41%
-
Exercise·M
CHIEF REGULATORY OFFICER · 10b5-1
$107.7K
36.8K sh · $2.93
Own +69%
-
Exercise·M
CHIEF MEDICAL OFFICER · 10b5-1
$0
50.0K sh
Own +13%
-
Sell·S
CHIEF MEDICAL OFFICER · 10b5-1
$251.0K
50.0K sh · $5.02
Own -74%
-
Exercise·M
CHIEF MEDICAL OFFICER · 10b5-1
$97.0K
50.0K sh · $1.94
Own +278%
-
Exercise·M
CHIEF REGULATORY OFFICER · 10b5-1
$0
200.0K sh · 2 lots
Own +200%
-
Sell·S
CHIEF REGULATORY OFFICER · 10b5-1
$903.6K
200.0K sh · $4.52
Own -79%
-
Exercise·M
CHIEF REGULATORY OFFICER · 10b5-1
$381.0K
200.0K sh · $1.91 avg · 2 lots
Own +377%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | Mashal Robert | Buy P | 25.0K | $118.2K |
| May 21, 2026 | VERNON W ANTHONY | Grant A | 123.4K | $0 |
| May 21, 2026 | Mashal Robert | Grant A | 123.4K | $0 |
| May 21, 2026 | FALBERG KATHRYN E | Grant A | 123.4K | $0 |
| May 21, 2026 | Cui Xiangmin | Grant A | 123.4K | $0 |
| May 21, 2026 | Bazemore Robert B | Grant A | 123.4K | $0 |
| May 21, 2026 | BLICKENSTAFF KIM D | Grant A | 123.4K | $0 |
| Apr 17, 2026 | Wentworth Kerry 10b5-1 | Exercise M | 36.8K | $0 |
| Apr 17, 2026 | Wentworth Kerry 10b5-1 | Sell S | 36.8K | $184.3K |
| Apr 17, 2026 | Wentworth Kerry 10b5-1 | Exercise M | 36.8K | $107.7K |
| Apr 17, 2026 | Liu Dongfang 10b5-1 | Exercise M | 50.0K | $0 |
| Apr 17, 2026 | Liu Dongfang 10b5-1 | Sell S | 50.0K | $251.0K |
| Apr 17, 2026 | Liu Dongfang 10b5-1 | Exercise M | 50.0K | $97.0K |
| Apr 6, 2026 | Wentworth Kerry 10b5-1 | Exercise M | 200.0K2 lots | $0 |
| Apr 6, 2026 | Wentworth Kerry 10b5-1 | Sell S | 200.0K | $903.6K |
| Apr 6, 2026 | Wentworth Kerry 10b5-1 | Exercise M | 200.0K2 lots | $381.0K |
Buy Sell Non-market (grant · exercise · gift)
About NUVB insider trading
This page tracks insider transactions for Nuvation Bio Inc. (NUVB) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.